01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships

Croissy-Beaubourg, July, 1, 2020, 5:45 pm CEST – The University of Tours and THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics,…

Continue Reading 01/07/2020 : The University of Tours and Theradiag sign two agreements simultaneously: an exclusive licensing agreement for the production of COVID-19 viral proteins and a global collaboration agreement that could lead to the creation of further partnerships

18/11/2019 : THERADIAG announces CE marking approval for its new i-Track10 automated analyzer for biotherapy monitoring

Télécharger/Download Croissy-Beaubourg, November 18, 2019, 8:00 am CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has obtained the CE marking for its i-Track10…

Continue Reading 18/11/2019 : THERADIAG announces CE marking approval for its new i-Track10 automated analyzer for biotherapy monitoring